Immunotherapy with cat- and dog-dander extracts. V. Effects of 3 years of treatment
about
The major dog allergens, Can f 1 and Can f 2, are salivary lipocalin proteins: cloning and immunological characterization of the recombinant formsNew vaccines for Mammalian allergy using molecular approachesDesigning a multimer allergen for diagnosis and immunotherapy of dog allergic patients.Fel d 1-airway inflammation prevention and treatment by co-immunization vaccine via induction of CD4+CD25-Foxp3+ Treg cellsActual therapeutic management of allergic and hyperreactive nasal disordersGuideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical AssoConsensus Guidelines on Practical Issues of Immunotherapy-Canadian Society of Allergy and Clinical Immunology (CSACI).Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergy.Hypoallergenic derivatives of Fel d 1 obtained by rational reassembly for allergy vaccination and tolerance induction.Allergen-specific immunotherapy provides immediate, long-term and preventive clinical effects in children and adults: the effects of immunotherapy can be categorised by level of benefit -the centenary of allergen specific subcutaneous immunotherapy.Clustering of conformational IgE epitopes on the major dog allergen Can f 1.Anti-inflammatory effects of pre-seasonal Th1-adjuvant vaccine to Parietaria judaica in asthmaticsSub-lingual immunotherapy: world allergy organization position paper 2009.
P2860
Q24538280-96971CFB-A811-4392-9C80-9D181515814FQ26998820-E23208E1-97C0-4705-9EEF-21B196B256DEQ34420851-AB43023B-7C46-4A54-856F-F7C6508415AAQ34647312-7930A8DB-5DBA-4BD4-96C1-39B771393230Q35427205-EE9C5C4F-DA6D-4D81-8D66-EB0CE693513EQ35777126-54B4DEA3-90AC-46F4-9B6F-3EA541D4176EQ40744033-67848359-D44C-4472-B1E5-222B969DF103Q41895016-370AB3B0-9A05-44F2-9B1B-D5CB3A36CE1FQ42143464-C8040959-CE73-4C16-89F4-EE4EF5264706Q42153928-FF661073-CA1F-43A0-A9ED-3975144FF588Q42252694-0E9E0BE8-11DB-4497-8D3E-73544E47EEBDQ42746357-54E53970-DA3B-41A0-92B1-5ECF8E4D074CQ55527154-A30EF80B-AE82-4CC9-BAB7-A3E43E230990
P2860
Immunotherapy with cat- and dog-dander extracts. V. Effects of 3 years of treatment
description
1991 nî lūn-bûn
@nan
1991 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Immunotherapy with cat- and dog-dander extracts. V. Effects of 3 years of treatment
@ast
Immunotherapy with cat- and dog-dander extracts. V. Effects of 3 years of treatment
@en
Immunotherapy with cat- and dog-dander extracts. V. Effects of 3 years of treatment
@nl
type
label
Immunotherapy with cat- and dog-dander extracts. V. Effects of 3 years of treatment
@ast
Immunotherapy with cat- and dog-dander extracts. V. Effects of 3 years of treatment
@en
Immunotherapy with cat- and dog-dander extracts. V. Effects of 3 years of treatment
@nl
prefLabel
Immunotherapy with cat- and dog-dander extracts. V. Effects of 3 years of treatment
@ast
Immunotherapy with cat- and dog-dander extracts. V. Effects of 3 years of treatment
@en
Immunotherapy with cat- and dog-dander extracts. V. Effects of 3 years of treatment
@nl
P2093
P1476
Immunotherapy with cat- and dog-dander extracts. V. Effects of 3 years of treatment
@en
P2093
H Heilborn
H Lowenstein
K Norrlind
V Graff-Lonnevig
P304
P407
P577
1991-05-01T00:00:00Z